Report Detail
Global Anti-Hypertensive Drugs Market Insights and Forecast to 2026
- RnM4166702 |
- 26 August, 2020 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Hypertensive Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Hypertensive Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Hypertensive Drugs market is segmented into
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators
Renin Inhibitors
Segment by Application, the Anti-Hypertensive Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
The Anti-Hypertensive Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Hypertensive Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Hypertensive Drugs Market Share Analysis
Anti-Hypertensive Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Hypertensive Drugs business, the date to enter into the Anti-Hypertensive Drugs market, Anti-Hypertensive Drugs product introduction, recent developments, etc.
The major vendors covered:
Novartis
Pfizer
Johnson & Johnson
Sanofi
Lupin
Ranbaxy Laboratories
Merck
AstraZeneca
Daiichi Sankyo Company Limited
Takeda Pharmaceutical
1 Study Coverage
- 1.1 Anti-Hypertensive Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Hypertensive Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Type
- 1.4.2 Diuretics
- 1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
- 1.4.4 Angiotensin Receptor Blockers (ARBs)
- 1.4.5 Calcium Channel Blockers
- 1.4.6 Beta Blockers
- 1.4.7 Alpha Blockers
- 1.4.8 Vasodilators
- 1.4.9 Renin Inhibitors
- 1.5 Market by Application
- 1.5.1 Global Anti-Hypertensive Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Hypertensive Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Hypertensive Drugs Revenue 2015-2026
- 2.1.2 Global Anti-Hypertensive Drugs Sales 2015-2026
- 2.2 Global Anti-Hypertensive Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Hypertensive Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Hypertensive Drugs Competitor Landscape by Players
- 3.1 Anti-Hypertensive Drugs Sales by Manufacturers
- 3.1.1 Anti-Hypertensive Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Hypertensive Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Hypertensive Drugs Revenue by Manufacturers
- 3.2.1 Anti-Hypertensive Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Hypertensive Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Hypertensive Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Hypertensive Drugs Revenue in 2019
- 3.2.5 Global Anti-Hypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Hypertensive Drugs Price by Manufacturers
- 3.4 Anti-Hypertensive Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Hypertensive Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Hypertensive Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Hypertensive Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Hypertensive Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Hypertensive Drugs Sales by Type (2015-2020)
- 4.1.2 Global Anti-Hypertensive Drugs Revenue by Type (2015-2020)
- 4.1.3 Anti-Hypertensive Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Hypertensive Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Hypertensive Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Hypertensive Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Hypertensive Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Hypertensive Drugs Sales by Application (2015-2020)
- 5.1.2 Global Anti-Hypertensive Drugs Revenue by Application (2015-2020)
- 5.1.3 Anti-Hypertensive Drugs Price by Application (2015-2020)
- 5.2 Anti-Hypertensive Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Hypertensive Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Hypertensive Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Hypertensive Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Hypertensive Drugs by Country
- 6.1.1 North America Anti-Hypertensive Drugs Sales by Country
- 6.1.2 North America Anti-Hypertensive Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Hypertensive Drugs Market Facts & Figures by Type
- 6.3 North America Anti-Hypertensive Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Hypertensive Drugs by Country
- 7.1.1 Europe Anti-Hypertensive Drugs Sales by Country
- 7.1.2 Europe Anti-Hypertensive Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Hypertensive Drugs Market Facts & Figures by Type
- 7.3 Europe Anti-Hypertensive Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Hypertensive Drugs by Region
- 8.1.1 Asia Pacific Anti-Hypertensive Drugs Sales by Region
- 8.1.2 Asia Pacific Anti-Hypertensive Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Hypertensive Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Hypertensive Drugs by Country
- 9.1.1 Latin America Anti-Hypertensive Drugs Sales by Country
- 9.1.2 Latin America Anti-Hypertensive Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Hypertensive Drugs Market Facts & Figures by Type
- 9.3 Central & South America Anti-Hypertensive Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Hypertensive Drugs by Country
- 10.1.1 Middle East and Africa Anti-Hypertensive Drugs Sales by Country
- 10.1.2 Middle East and Africa Anti-Hypertensive Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Hypertensive Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Anti-Hypertensive Drugs Products Offered
- 11.1.5 Novartis Related Developments
- 11.2 Pfizer
- 11.2.1 Pfizer Corporation Information
- 11.2.2 Pfizer Description and Business Overview
- 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer Anti-Hypertensive Drugs Products Offered
- 11.2.5 Pfizer Related Developments
- 11.3 Johnson & Johnson
- 11.3.1 Johnson & Johnson Corporation Information
- 11.3.2 Johnson & Johnson Description and Business Overview
- 11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Johnson & Johnson Anti-Hypertensive Drugs Products Offered
- 11.3.5 Johnson & Johnson Related Developments
- 11.4 Sanofi
- 11.4.1 Sanofi Corporation Information
- 11.4.2 Sanofi Description and Business Overview
- 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Sanofi Anti-Hypertensive Drugs Products Offered
- 11.4.5 Sanofi Related Developments
- 11.5 Lupin
- 11.5.1 Lupin Corporation Information
- 11.5.2 Lupin Description and Business Overview
- 11.5.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Lupin Anti-Hypertensive Drugs Products Offered
- 11.5.5 Lupin Related Developments
- 11.6 Ranbaxy Laboratories
- 11.6.1 Ranbaxy Laboratories Corporation Information
- 11.6.2 Ranbaxy Laboratories Description and Business Overview
- 11.6.3 Ranbaxy Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Ranbaxy Laboratories Anti-Hypertensive Drugs Products Offered
- 11.6.5 Ranbaxy Laboratories Related Developments
- 11.7 Merck
- 11.7.1 Merck Corporation Information
- 11.7.2 Merck Description and Business Overview
- 11.7.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Merck Anti-Hypertensive Drugs Products Offered
- 11.7.5 Merck Related Developments
- 11.8 AstraZeneca
- 11.8.1 AstraZeneca Corporation Information
- 11.8.2 AstraZeneca Description and Business Overview
- 11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 AstraZeneca Anti-Hypertensive Drugs Products Offered
- 11.8.5 AstraZeneca Related Developments
- 11.9 Daiichi Sankyo Company Limited
- 11.9.1 Daiichi Sankyo Company Limited Corporation Information
- 11.9.2 Daiichi Sankyo Company Limited Description and Business Overview
- 11.9.3 Daiichi Sankyo Company Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Daiichi Sankyo Company Limited Anti-Hypertensive Drugs Products Offered
- 11.9.5 Daiichi Sankyo Company Limited Related Developments
- 11.10 Takeda Pharmaceutical
- 11.10.1 Takeda Pharmaceutical Corporation Information
- 11.10.2 Takeda Pharmaceutical Description and Business Overview
- 11.10.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Takeda Pharmaceutical Anti-Hypertensive Drugs Products Offered
- 11.10.5 Takeda Pharmaceutical Related Developments
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Anti-Hypertensive Drugs Products Offered
- 11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Hypertensive Drugs Market Estimates and Projections by Region
- 12.1.1 Global Anti-Hypertensive Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Hypertensive Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Hypertensive Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Hypertensive Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Hypertensive Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Hypertensive Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Hypertensive Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Hypertensive Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Hypertensive Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Hypertensive Drugs. Industry analysis & Market Report on Anti-Hypertensive Drugs is a syndicated market report, published as Global Anti-Hypertensive Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Anti-Hypertensive Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
